Literature DB >> 24002505

Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.

Gregory T Armstrong1, Kevin C Oeffinger, Yan Chen, Toana Kawashima, Yutaka Yasui, Wendy Leisenring, Marilyn Stovall, Eric J Chow, Charles A Sklar, Daniel A Mulrooney, Ann C Mertens, William Border, Jean-Bernard Durand, Leslie L Robison, Lillian R Meacham.   

Abstract

PURPOSE: To evaluate the relative contribution of modifiable cardiovascular risk factors on the development of major cardiac events in aging adult survivors of childhood cancer. PATIENTS AND METHODS: Among 10,724 5-year survivors (median age, 33.7 years) and 3,159 siblings in the Childhood Cancer Survivor Study, the prevalence of hypertension, diabetes mellitus, dyslipidemia, and obesity was determined, along with the incidence and severity of major cardiac events such as coronary artery disease, heart failure, valvular disease, and arrhythmia. On longitudinal follow-up, rate ratios (RRs) of subsequent cardiac events associated with cardiovascular risk factors and cardiotoxic therapy were assessed in multivariable Poisson regression models.
RESULTS: Among survivors, the cumulative incidence of coronary artery disease, heart failure, valvular disease, and arrhythmia by 45 years of age was 5.3%, 4.8%, 1.5%, and 1.3%, respectively. Two or more cardiovascular risk factors were reported by 10.3% of survivors and 7.9% of siblings. The risk for each cardiac event increased with increasing number of cardiovascular risk factors (all P(trend) < .001). Hypertension significantly increased risk for coronary artery disease (RR, 6.1), heart failure (RR, 19.4), valvular disease (RR, 13.6), and arrhythmia (RR, 6.0; all P values < .01). The combined effect of chest-directed radiotherapy plus hypertension resulted in potentiation of risk for each of the major cardiac events beyond that anticipated on the basis of an additive expectation. Hypertension was independently associated with risk of cardiac death (RR, 5.6; 95% CI, 3.2 to 9.7).
CONCLUSION: Modifiable cardiovascular risk factors, particularly hypertension, potentiate therapy-associated risk for major cardiac events in this population and should be the focus of future interventional studies.

Entities:  

Mesh:

Year:  2013        PMID: 24002505      PMCID: PMC3804290          DOI: 10.1200/JCO.2013.49.3205

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  32 in total

1.  Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative.

Authors:  Susan R Heckbert; Charles Kooperberg; Monika M Safford; Bruce M Psaty; Judith Hsia; Anne McTiernan; J Michael Gaziano; William H Frishman; J David Curb
Journal:  Am J Epidemiol       Date:  2004-12-15       Impact factor: 4.897

2.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

3.  The progression from hypertension to congestive heart failure.

Authors:  D Levy; M G Larson; R S Vasan; W B Kannel; K K Ho
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

4.  Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.

Authors:  Wendy Landier; Smita Bhatia; Debra A Eshelman; Katherine J Forte; Teresa Sweeney; Allison L Hester; Joan Darling; F Daniel Armstrong; Julie Blatt; Louis S Constine; Carolyn R Freeman; Debra L Friedman; Daniel M Green; Neyssa Marina; Anna T Meadows; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Kathleen S Ruccione; Charles A Sklar; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2004-12-02       Impact factor: 44.544

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

7.  Utility of self-reported diagnosis and electrocardiogram Q-waves for estimating myocardial infarction prevalence: an international comparison study.

Authors:  Andrew Moran; Albert Shen; Daniel Turner-Lloveras; Aayla Khan; Els Clays; Walter Palmas; Dirk De Bacquer
Journal:  Heart       Date:  2012-09-02       Impact factor: 5.994

8.  Clinical factors and angiographic features associated with premature coronary artery disease.

Authors:  L Chen; M Chester; J C Kaski
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

9.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.

Authors:  S E Lipshultz; S D Colan; R D Gelber; A R Perez-Atayde; S E Sallan; S P Sanders
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

10.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

Authors:  Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  Med Pediatr Oncol       Date:  2002-04
View more
  194 in total

Review 1.  Collaborative Research in Childhood Cancer Survivorship: The Current Landscape.

Authors:  Smita Bhatia; Saro H Armenian; Gregory T Armstrong; Eline van Dulmen-den Broeder; Michael M Hawkins; Leontien C M Kremer; Claudia E Kuehni; Jørgen H Olsen; Leslie L Robison; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

2.  Validity of anthropometric measurements for characterizing obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study.

Authors:  Robyn E Karlage; Carmen L Wilson; Nan Zhang; Sue Kaste; Daniel M Green; Gregory T Armstrong; Leslie L Robison; Wassim Chemaitilly; Deo Kumar Srivastava; Melissa M Hudson; Kirsten K Ness
Journal:  Cancer       Date:  2015-02-27       Impact factor: 6.860

3.  Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.

Authors:  Lang Li; Tammy Sajdyk; Ellen M L Smith; Chien Wei Chang; Claire Li; Richard H Ho; Raymond Hutchinson; Elizabeth Wells; Jodi L Skiles; Naomi Winick; Paul L Martin; Jamie L Renbarger
Journal:  Clin Pharmacol Ther       Date:  2019-01-21       Impact factor: 6.875

4.  Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.

Authors:  Kasey J Leger; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Wendy M Leisenring; Paul J Martin; Jason A Mendoza; Kerryn W Reding; Karen L Syrjala; Stephanie J Lee; Eric J Chow
Journal:  Cancer       Date:  2018-01-09       Impact factor: 6.860

5.  Parental Considerations Regarding Cure and Late Effects for Children With Cancer.

Authors:  Katie A Greenzang; Hasan Al-Sayegh; Clement Ma; Mehdi Najafzadeh; Eve Wittenberg; Jennifer W Mack
Journal:  Pediatrics       Date:  2020-04-13       Impact factor: 7.124

6.  Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity.

Authors:  Fei Wang; Brian Iskra; Eugenie Kleinerman; Claudia Alvarez-Florez; Thomas Andrews; Angela Shaw; Joya Chandra; Keri Schadler; Gregory J Aune
Journal:  J Pediatr Hematol Oncol       Date:  2018-04       Impact factor: 1.289

Review 7.  Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges.

Authors:  Debashish Das; Alex Asher; Arjun K Ghosh
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

Review 8.  Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.

Authors:  Peggy M Kostakou; Nikos T Kouris; Vassilios S Kostopoulos; Dimitrios S Damaskos; Christoforos D Olympios
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

9.  Cigarette smoking and pulmonary function in adult survivors of childhood cancer exposed to pulmonary-toxic therapy: results from the St. Jude lifetime cohort study.

Authors:  S Cristina Oancea; James G Gurney; Kirsten K Ness; Rohit P Ojha; Vida L Tyc; James L Klosky; DeoKumar Srivastava; Dennis C Stokes; Leslie L Robison; Melissa M Hudson; Daniel M Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-17       Impact factor: 4.254

Review 10.  Obesity and Metabolic Syndrome Among Adult Survivors of Childhood Leukemia.

Authors:  Todd M Gibson; Matthew J Ehrhardt; Kirsten K Ness
Journal:  Curr Treat Options Oncol       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.